Jiani Gao

427 total citations
17 papers, 261 citations indexed

About

Jiani Gao is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Jiani Gao has authored 17 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Jiani Gao's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Jiani Gao is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Jiani Gao collaborates with scholars based in China, United States and Chile. Jiani Gao's co-authors include Hang Su, Chang Chen, Yijiu Ren, Haipeng Liu, Henner Hollert, Yajuan Cao, Qiqing Chen, Hairui Yu, Yan Yang and Huahong Shi and has published in prestigious journals such as CHEST Journal, British Journal of Cancer and Cell Reports.

In The Last Decade

Jiani Gao

15 papers receiving 258 citations

Peers

Jiani Gao
Jiani Gao
Citations per year, relative to Jiani Gao Jiani Gao (= 1×) peers Qingdong Cao

Countries citing papers authored by Jiani Gao

Since Specialization
Citations

This map shows the geographic impact of Jiani Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiani Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiani Gao more than expected).

Fields of papers citing papers by Jiani Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiani Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiani Gao. The network helps show where Jiani Gao may publish in the future.

Co-authorship network of co-authors of Jiani Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Jiani Gao. A scholar is included among the top collaborators of Jiani Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiani Gao. Jiani Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Su, Hang, Changyong Hu, Jianxia Chen, et al.. (2025). Development of antibody drug conjugates targeting epithelial membrane protein 2-highly expressed lung cancer. Cell Death and Disease. 16(1). 771–771.
2.
Ma, Mingtong, Mengmeng Zhao, Yajuan Cao, et al.. (2025). Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity. Cell Reports. 44(5). 115572–115572. 1 indexed citations
5.
Li, Yang, Jiani Gao, Yuqin Zhang, et al.. (2023). Protective effects of palbociclib on colitis-associated colorectal cancer. Journal of Gastrointestinal Oncology. 14(6). 2436–2447. 4 indexed citations
6.
Xu, Long, Hang Su, Shengnan Zhao, et al.. (2023). Development of the semi-dry dot-blot method for intraoperative detecting micropapillary component in lung adenocarcinoma based on proteomics analysis. British Journal of Cancer. 128(11). 2116–2125. 1 indexed citations
7.
Chen, Qiqing, Jiani Gao, Hairui Yu, et al.. (2022). An emerging role of microplastics in the etiology of lung ground glass nodules. Environmental Sciences Europe. 34(1). 124 indexed citations
8.
Gao, Jiani, Xiangyang Wu, Hang Su, et al.. (2022). CDK inhibitor Palbociclib targets STING to alleviate autoinflammation. EMBO Reports. 23(6). e53932–e53932. 46 indexed citations
9.
Li, Zhixin, et al.. (2022). Is VATS approach suitable in re-operations for postoperative hemothorax after pulmonary resection? Data analysis in a big volume thoracic center. Journal of Cardiothoracic Surgery. 17(1). 310–310. 2 indexed citations
10.
Zhang, Yucheng, Yanyun Wang, Jiani Gao, et al.. (2022). Positively charged and neutral drug-loaded liposomes as the aerosolized formulations for the efficiency assessment of tumor metastases to lungs. Journal of Drug Delivery Science and Technology. 80. 104081–104081. 4 indexed citations
11.
Xu, Long, Hang Su, Likun Hou, et al.. (2022). The IASLC Proposed Grading System Accurately Predicts Prognosis and Mediastinal Nodal Metastasis in Patients With Clinical Stage I Lung Adenocarcinoma. The American Journal of Surgical Pathology. 46(12). 1633–1641. 14 indexed citations
12.
Wang, Fang, Hang Su, Minglei Yang, et al.. (2022). Reconsidering T component of cancer staging for T3/T4 non-small-cell lung cancer with additional nodule. Therapeutic Advances in Medical Oncology. 14. 4287542534–4287542534. 3 indexed citations
14.
Zhao, Mengmeng, Junqi Wu, Jiajun Deng, et al.. (2021). Proposal for Rib invasion as an independent T descriptor for non-small cell lung cancer: A propensity-score matching analysis. Lung Cancer. 159. 27–33. 4 indexed citations
15.
Xu, Long, Hang Su, Yunlang She, et al.. (2020). Which N Descriptor Is More Predictive of Prognosis in Resected Non-small Cell Lung Cancer. CHEST Journal. 159(6). 2458–2469. 22 indexed citations
16.
Gao, Jiani, Yijiu Ren, Haoyue Guo, et al.. (2020). A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratio. Annals of Translational Medicine. 8(7). 470–470. 13 indexed citations
17.
Deng, Jiajun, Mengmeng Zhao, Tingting Wang, et al.. (2020). A modified T categorization for part-solid lesions in Chinese patients with clinical stage I Non–small cell lung cancer. Lung Cancer. 145. 33–39. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026